Supply of PVMS Vaccines to Directorate of Procurement Navy Islamabad

This tender invites qualified firms to supply PVMS vaccines to the Directorate of Procurement (Navy) located in Islamabad. The procurement focuses on pharmaceutical supplies essential for medical stores, specifically vaccines listed under PVMS. The department requires firms to submit sealed technical and commercial offers following a two-envelope bidding procedure, ensuring compliance with detailed technical specifications and brand evaluations. The supply involves vaccines such as Mennigococcal and Yellow Fever vaccines, with strict adherence to shelf life, packaging, and labeling standards. Delivery is scheduled for the financial year 2026-27, with quarterly supply orders. The Islamabad location demands careful logistics management to maintain cold chain facilities and timely delivery within 30 days of supply orders. The tender emphasizes quality control, including inspection and testing by authorized agencies, ensuring all vaccines meet national and international standards. Bidders must be registered with DGDP or willing to register, possess valid licenses, GMP and ISO certifications, and be on the Active Taxpayers List (ATL) of FBR. Earnest money requirements vary by firm category, and compliance with PPRA Rules 2004 and DPP&I-35 (Revised 2024) is mandatory. Firms must submit all required documentation including technical offers, commercial offers, and supporting certificates to avoid disqualification. The submission deadline is set for 10:30 AM on 2nd April 2026, with bid opening at 11:00 AM the same day at the Directorate of Procurement (Navy), Naval Residential Complex, Sector E-8, Islamabad. Offers must be delivered in sealed envelopes clearly marked and addressed to the procurement office. Late submissions will be rejected without exception. Pro-Tip: Ensure your technical offer strictly follows the Annex-A format and includes all required documents such as DGDP registration, GMP certificates, and proof of Earnest Money. Missing or incomplete documentation is a common cause for rejection. Also, verify your firm's ATL status with FBR before submission to avoid disqualification.